The stock of AC Immune SA (NASDAQ:ACIU) last traded at $2.74, up 2.24% from the previous session.
ACIU stock price is now -1.73% away from the 50-day moving average and -16.85% away from the 200-day moving average. The market capitalization of the company currently stands at $273.12M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $8, BTIG Research recently initiated with Buy rating for AC Immune SA (NASDAQ: ACIU)., while ‘H.C. Wainwright’ rates the stock as ‘Buy’
In other news, ANDREA M. A PFEIFER, Officer bought 40,000 shares of the company’s stock on Sep 27 ’24. The stock was bought for $148,000 at an average price of $3.70. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 18 ’24, Officer ANDREA M. A PFEIFER bought 20,000 shares of the business’s stock. A total of $69,200 was incurred on buying the stock at an average price of $3.46. A total of 37.89% of the company’s stock is owned by insiders.
During the past 12 months, AC Immune SA has had a low of $2.25 and a high of $4.98. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 1.86, and a quick ratio of 1.86. The fifty day moving average price for ACIU is $2.7883 and a two-hundred day moving average price translates $3.29535 for the stock.
The latest earnings results from AC Immune SA (NASDAQ: ACIU) was released for 2024-09-30. The net profit margin was -95.16% and return on equity was -30.57% for ACIU.
